Clinical Trials Browser

Phase 2 × PM 01183 × 30 days × Clear all

NCT07155174 2026-04-14

SEZanne

Phase 2 Recruiting

Small Cell Lung Carcinoma

NCT07328425 2026-04-03

ISG-TULIPS

Phase 2 Recruiting

Desmoplastic Small Round Cell Tumor

NCT04607954 2026-03-31

Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer

Phase 2 Active not recruiting

Platinum-Resistant Lung Small Cell Carcinoma

NCT05578326 2026-03-30

Study of Trilaciclib and Lurbinectidin

Phase 2 Recruiting

Lung Neoplasms, Neutropenia, Small Cell Lung Carcinoma